Risk factors for severe maternal morbidity in patients with hypertensive disorder of pregnancy: A retrospective study

被引：0

作者：

Fang, Zhuanji ^{[1
]}

Zhang, Huale ^{[1
]}

Xu, Guizhen ^{[1
]}

Zhang, Qinjian ^{[1
]}

Huang, Liping ^{[1
]}

Yan, Jianying ^{[1
]}

机构：

[1] Fujian Med Univ, Fujian Matern & Child Hlth Hosp, Coll Clin Med Obstet & Gynecol & Pediat, Dept Obstet & Gynecol, 18 Daoshan Rd, Fuzhou 350001, Fujian Province, Peoples R China

来源：

PAKISTAN JOURNAL OF MEDICAL SCIENCES | 2025年 / 41卷 / 07期

关键词：

Hypertensive disorder of pregnancy; Iron supplementation; Preeclampsia; Risk factors; Severe maternal morbidity; BLOOD-PRESSURE; PREECLAMPSIA; REDUCTION; MORTALITY; DELIVERY; AGE;

D O I：

10.12669/pjms.41.7.12023

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: To identify significant risk factors associated with severe maternal morbidity(SMM) in patients with hypertensive disorder of pregnancy (HDP). Methods: This retrospective study analyzed clinical data from patients with HDP who delivered at Fujian Maternity and Children Health Hospital between January 2013 and March 2022. Univariate logistic regression analysis was performed to identify risk factors for developing SMM. Significant risk factors (P < 0.05) were considered for inclusion in multivariate logistic regression using stepwise regression with forward and backward selection. Results: Of 3133 HDP patients included in the study, 365 met the diagnostic criteria of SMM and were included in the SMM group, while 2768 patients comprised the control group. The SMM group had a significantly higher incidence of gestational hypertension diagnosed at <= 34 weeks of gestation compared to the control group (30.14% vs. 12.64%, p<0.0001). Patients in the SMM group had a higher incidence of previous history of preeclampsia compared to the control group (1.64% vs. 0.25%, p=0.0001). Logistic regression analysis identified parity (OR, 1.37; CI, 1.05-1.78; p=0.0205), gestational age of diagnosis (OR, 2.22; CI, 1.68-2.92; p<0.0001), iron supplementation (OR, 2.31; CI, 1.83-2.93; p<0.0001), and preeclampsia (OR, 3.10; CI, 2.42-3.98; p<0.0001) as significant risk factors for SMM. Stepwise regression analysis confirmed that parity (OR, 1.43; CI, 1.17-1.73; p=0.0004), gestational age of diagnosis (OR, 2.32; CI, 1.77-3.05; p<0.0001), iron supplementation (OR, 2.30; CI, 1.82-2.90; p<0.0001), and preeclampsia (OR, 3.34; CI, 2.63-4.24; p<0.0001) remained significantly associated with SMM. Conclusion: Gestational age of diagnosis, iron supplementation, and history of preeclampsia were identified as risk factors of SMM in patients with HDP. Our results can help identify high-risk patients for early recognition and management of SMM.

引用

页码：1872 / 1880

页数：9

共 38 条

[1]

Garovic VD, Dechend R, Easterling T, Karumanchi SA, McMurtry Baird S, Ma-gee LA, Et al., Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association, Hypertension, 79, 2, pp. e21-e41, (2022)

[2]

Petersen EE, Davis NL, Goodman D, Cox S, Mayes N, Johnston E, Et al., Vital Signs: Pregnancy-Related Deaths, United States, 2011-2015, and Strategies for Prevention, 13 States, 2013-2017, Morb Mortal Wkly Rep, 68, 18, pp. 423-429, (2019)

[3]

Ananth CV, Vintzileos AM., Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth, Am J Obstet Gynecol, 195, 6, pp. 1557-1563, (2006)

[4]

Duley L., The global impact of pre-eclampsia and eclampsia, Semin Perinatol, 33, 3, pp. 130-137, (2009)

[5]

Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, Et al., The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice, Pregnancy Hyper-tens, 13, pp. 291-310, (2018)

[6]

Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniels J, Et al., Global causes of maternal death: a WHO systematic analysis, Lancet Glob Health, 2, 6, pp. e323-e333, (2014)

[7]

Souza JP, Gulmezoglu AM, Vogel J, Carroli G, Lumbiganon P, Qureshi Z, Et al., Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study, Lancet, 381, 9879, pp. 1747-1755, (2013)

[8]

Liu S, Liston RM, Joseph KS, Heaman M, Sauve R, Kramer MS, Et al., Maternal mortality and severe morbidity associated with low-risk planned cesarean delivery versus planned vaginal delivery at term, CMAJ, 176, 4, pp. 455-460, (2007)

[9]

Say L, Souza JP, Pattinson RC., WHO working group on Maternal Mortality and Morbidity classifications. Maternal near miss--towards a standard tool for monitoring quality of maternal health care, Best Pract Res Clin Obstet Gynaecol, 23, 3, pp. 287-296, (2009)

[10]

Tan J, Chen M, Li Y, Liu X, Yu C, Sun X., Modeling to Predict Severe Maternal Morbidity Based on 33993 Deliveries of Registered Study in China, Value Health, 17, 7, (2014)

← 1 2 3 4 →